Many clinical trials are underway for drugs to combat COVID-19, but the FDA gave special notice to two drugs. Gilead Sciences initiated two Phase 3 studies of the investigational antiviral...
...Alzheimer’s could interfere with medication adherence, particularly if patients also have a comorbidity. For ongoing coverage of the latest drug approvals and alerts impacting workers’ comp, visit Med Monitor online....
Healthesystems’ VP of Clinical Services, Silvia Sacalis, BS, PharmD, was featured in the International Association of Industrial Accident Boards and Commissions’ (IAIABC) Perspectives publication. Dr. Sacalis penned an article on...
Healthesystems' Advocacy and Compliance team recently attended the NCCI Annual Insights Symposium in Orlando, Florida. This event brings together executive leaders and actuaries from the workers' compensation industry to hear...
...drug would be the first oral antiviral medication for COVID-19. For all of the latest updates on FDA drug approvals impacting workers’ comp, check out our interactive web tool, MedMonitor....
...populations include healthcare workers. Recently, ViiV Healthcare, a GlaxoSmithKline company, communicated to the FDA that several HIV medications they manufacture will be discontinued by the end of 2023. While many...
...for Priority Review the New Drug Application (NDA) for MDMA capsules in combination with psychological intervention for the treatment of PTSD. While this has been long coming, with the FDA...
...framework under the Nebraska Medical Cannabis Patient Protection Act and Regulation Act but would not require the costs of cannabis to be covered by employers, insurance companies or workers’ comp...
...or chewed. Auvelity is expected to hit the market in Q4 of 2022. For ongoing coverage of the latest drug approvals and alerts impacting workers’ comp, visit Med Monitor online....
Explore the latest social media posts from Healthesystems on Facebook, Instagram, LinkedIn, X (Twitter), and Youtube. YouTube Twitter Instagram LinkedIn Facebook...
...is projecting a shortfall of 600,000 home care workers in the next 10 years, according to the California Future Health Workforce Commission. Concurrently, there is increased competition for those direct...
The Workers’ Compensation Research Institute (WCRI) published a new Flash Report on interstate variation and trends in workers’ comp drug payments from Q1 of 2016 to Q1 of 2019. This report presents...
...impact of medical marijuana from the public policy and healthcare perspectives – including workers’ compensation. Marijuana’s growing support has unfolded a variety of complex and multifaceted considerations that impact care...
...finalization expected by August. Plan-Based Audit: New audit underway on designated doctor referrals/testing; draft to be shared for feedback once complete. AMA Guides Study: DWC evaluating adoption of a more...
The Centers for Disease Control and Prevention (CDC) awarded $279 million to 49 states, the District of Columbia, and 40 local health departments to help stop overdoses within their communities....
